Ardian has sold pharmaceutical company Riemser to Spain-based drugs company Esteve in a deal that is expected to close in Q1 2020.
Insight Venture Partners previously led a €56m funding round early last year
Price led the strategic debt finance and capital structure advisory teams at Lloyds
Enterprise Investors wholly acquired the company in a carve-out from Budimex in December 2013
Melior Equity Partners' debut fund is targeting €200m, according to press reports